Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality

Feng Zhou(Wuhan University), Hongliang Li(Wuhan University), Xiang Da(Wuhan University), Yufeng Yuan(Wuhan University), Bing-Hong Zhang(Wuhan University), Haofeng Lu(First People's Hospital of Jingzhou), Qingbo Xu(Ministry of Education of the People's Republic of China), Bin Wu(Central South University), Juan‐Juan Qin(Wuhan University), Jingjing Cai(Central South University), Zhi‐Gang She(Wuhan University), Xinliang Ma(Thomas Jefferson University), Zhigang Lu(First People’s Hospital of Jingmen), Jing Xie(Wuhan University), Ye-Mao Liu(Wuhan University), Daihong Wang(Xianning Central Hospital), Haomiao Li(Wuhan University), Peter P. Liu(University of Ottawa), Peng Zhang(Zhongnan Hospital of Wuhan University), Jun Yang(China Three Gorges University), Yibin Wang(Jiangsu University), Jiahong Xia(Union Hospital), Gang Peng(Suizhou Central Hospital), Xiaodong Huang, Xigang Xia(Jingzhou Central Hospital), Xia Meng(Wuhan University), Xiaofeng Liao(Gateway Community College), Chengzhang Yang(Wuhan University), Xiao-Jing Zhang(Wuhan University), Fang Lei(Wuhan University), Huilin Yang(Soochow University), Wei Xiang(Soochow University)
Hypertension
June 4, 2020
Cited by 65


Related Papers